2024
5 industry leaders share strategies to navigate the complexities of EU Joint Assessments—from data coordination and stakeholder engagement to transparency and market access.


5 industry leaders share strategies to navigate the complexities of EU Joint Assessments—from data coordination and stakeholder engagement to transparency and market access.






Director Global Pricing & Market Access, medac GmbH


Global Head, Market Access & Pricing – Primary and Acute Care, MENARINI Group


Director, Access Lead Cardio, Renal & Vascular Diseases, Bayer AG


Head of Market Access & Public Affairs CEE, Chiesi Group


Head of Market Access Department, Hemofarm AD


Chief Commercial Officer, CubeRM


VP Commercialization & BD, Memo Therapeutics


Corporate Vice President, Head of Global Market Access TA Inflammation, Boehringer Ingelheim


Senior Manager Market Access Operations, Amicus Therapeutics

Senior Consultant, CertaraMirkka Schaller

Head of Medical Platforms & Enablement

Associate Vice-President – Strategy & Marketing – SAMETA (South Asia, Middle-East, Turkey and Africa)


